These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21565604)

  • 1. Psychosis, ivermectin toxicity, and "Morgellons disease".
    DeBonis K; Pierre JM
    Psychosomatics; 2011; 52(3):295-6. PubMed ID: 21565604
    [No Abstract]   [Full Text] [Related]  

  • 2. Morgellons disease treatment with quetiapine.
    Carrillo de Albornoz Calahorro CM; López-Delgado D; Gutiérrez-Rojas L
    Med Clin (Barc); 2019 Feb; 152(3):118-119. PubMed ID: 29706457
    [No Abstract]   [Full Text] [Related]  

  • 3. Morgellons disease, or antipsychotic-responsive delusional parasitosis, in an HIV patient: beliefs in the age of the Internet.
    Freudenreich O; Kontos N; Tranulis C; Cather C
    Psychosomatics; 2010; 51(6):453-7. PubMed ID: 21051675
    [No Abstract]   [Full Text] [Related]  

  • 4. Folie à deux and Delusional Parasitosis.
    Giam A; Tung YL; Tibrewal P; Dhillon R; Bastiampillai T
    Asian J Psychiatr; 2017 Aug; 28():152-153. PubMed ID: 28784373
    [No Abstract]   [Full Text] [Related]  

  • 5. Suspected ivermectin toxicosis in a miniature mule foal causing blindness.
    Plummer CE; Kallberg ME; Ollivier FJ; Brooks DE; Gelatt KN
    Vet Ophthalmol; 2006; 9(1):29-32. PubMed ID: 16409242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of ivermectin overdose in a miniature Shetland Pony using intravenous administration of a lipid emulsion.
    Bruenisholz H; Kupper J; Muentener CR; Dally A; Kraemer T; Naegeli H; Schwarzwald CC
    J Vet Intern Med; 2012; 26(2):407-11. PubMed ID: 22300298
    [No Abstract]   [Full Text] [Related]  

  • 7. The challenge of Morgellons disease: A patient with clinicopathologic correlation.
    Caputo V; Bonoldi E; Citterio A; Rongioletti F
    Clin Dermatol; 2022; 40(6):686-690. PubMed ID: 35905899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morgellons disease etiology and therapeutic approach: a systematic review.
    Beuerlein KG; Balogh EA; Feldman SR
    Dermatol Online J; 2021 Aug; 27(8):. PubMed ID: 34755952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations on the drug treatment of psychosis in Parkinson's disease.
    Friedman JH
    Am J Med; 2010 Apr; 123(4):e19; author reply e21. PubMed ID: 20362738
    [No Abstract]   [Full Text] [Related]  

  • 11. Information, consent and treatment of patients with Morgellons disease: an ethical perspective.
    Söderfeldt Y; Groß D
    Am J Clin Dermatol; 2014 Apr; 15(2):71-6. PubMed ID: 24671866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Introduction. Antipsychotic agents: clinical, economic, and legal considerations in the treatment of psychosis.
    Lehman AF
    J Clin Psychiatry; 1999; 60 Suppl 19():3-4. PubMed ID: 10507274
    [No Abstract]   [Full Text] [Related]  

  • 13. [Karl Leonhard's Cycloid Psychosis and its position in the field of the endogenous psychosis].
    Cetkovich-Bakmas MG
    Vertex; 2002; 13 Suppl 1():17-21. PubMed ID: 12122423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A psychosis proneness-persistence-impairment model of psychotic disorders].
    van Os J; Verkooyen R; Hendriks M; Henquet C; Bak M; Marcelis M; Delespaul P; Krabbendam L; Myin-Germeys I
    Tijdschr Psychiatr; 2008; 50 Spec no.():77-83. PubMed ID: 19067304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges in the management of early psychosis.
    Haddad PM; Chaudhry IB
    J Psychopharmacol; 2012 May; 26(5 Suppl):6-7. PubMed ID: 22572072
    [No Abstract]   [Full Text] [Related]  

  • 16. Aggression, grief, and conflict in a patient with psychosis: an integration of psychodynamic and cognitive-behavioral perspectives.
    Shea M; Goisman RM; Greenberg R
    Harv Rev Psychiatry; 2010; 18(3):195-205. PubMed ID: 20415635
    [No Abstract]   [Full Text] [Related]  

  • 17. Agitation and psychosis in dementia.
    Ballard C
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
    [No Abstract]   [Full Text] [Related]  

  • 18. Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Oechsner M; Korchounov A
    Hum Psychopharmacol; 2005 Apr; 20(3):203-5. PubMed ID: 15799011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic-valproic acid combination in treatment of psychotic symptoms: a three-case report.
    Wassef A; Watson DJ; Morrison P; Bryant S; Flack J
    J Clin Psychopharmacol; 1989 Feb; 9(1):45-8. PubMed ID: 2565347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quetiapine in adolescent psychosis.
    Healy E; Subotsky F; Pipe R
    J Am Acad Child Adolesc Psychiatry; 1999 Nov; 38(11):1329. PubMed ID: 10560217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.